Which platelet aggregating agent demonstrates a monophasic aggregation curve in optimal concentration?

Which platelet aggregating agent demonstrates a monophasic aggregation curve in optimal concentration?

• A. Thrombin
• B. Collagen
• C. Adenosine diphosphate (ADP)
• D. Epinephrine

Answer: (B)

The correct choice is collagen, which is known to induce a monophasic aggregation curve under optimal conditions. This means that when platelets are exposed to collagen at the right concentration, they will aggregate in a single, smooth phase without subsequent peaks. Collagen interacts directly with platelet receptors, such as glycoprotein VI, which triggers signaling pathways leading to platelet activation and aggregation. This process allows for a robust and rapid response, characteristic of the monophasic aggregation observed. In contrast, other agents can induce more complex aggregation profiles. For instance, thrombin typically leads to a biphasic aggregation response due to its ability to activate various pathways that form secondary waves of aggregation. Adenosine diphosphate (ADP) can also produce a biphasic response as it activates platelets and may provoke further shape changes and aggregation. Epinephrine tends to function differently by promoting aggregation through its own set of receptors, and similar to ADP, it can also lead to a biphasic response. Understanding these differences is crucial for interpreting platelet function tests and for using these agents in clinical settings effectively.

The correct choice is collagen, which is known to induce a monophasic aggregation curve under optimal conditions. This means that when platelets are exposed to collagen at the right concentration, they will aggregate in a single, smooth phase without subsequent peaks.

Collagen interacts directly with platelet receptors, such as glycoprotein VI, which triggers signaling pathways leading to platelet activation and aggregation. This process allows for a robust and rapid response, characteristic of the monophasic aggregation observed.

In contrast, other agents can induce more complex aggregation profiles. For instance, thrombin typically leads to a biphasic aggregation response due to its ability to activate various pathways that form secondary waves of aggregation. Adenosine diphosphate (ADP) can also produce a biphasic response as it activates platelets and may provoke further shape changes and aggregation. Epinephrine tends to function differently by promoting aggregation through its own set of receptors, and similar to ADP, it can also lead to a biphasic response.

Understanding these differences is crucial for interpreting platelet function tests and for using these agents in clinical settings effectively.